title: Iron chelators in myelodysplastic syndrome: to lower ferritin levels or to improve survival?
authors.forename: Theo
authors.initials: T
authors.lastname: de Witte
mesh_terms: D001565:Benzoates / Q000627:therapeutic use*; D000077588:Deferasirox; D000077543:Deferiprone; D005260:Female; D006801:Humans; D007502:Iron Chelating Agents / Q000627:therapeutic use*; D019190:Iron Overload / Q000188:drug therapy* / Q000209:etiology*; D008297:Male; D009190:Myelodysplastic Syndromes / Q000628:therapy*; D011728:Pyridones / Q000627:therapeutic use*; D065227:Transfusion Reaction; D014230:Triazoles / Q000627:therapeutic use*
chemical_list: D001565:Benzoates; D007502:Iron Chelating Agents; D011728:Pyridones; D014230:Triazoles; D000077543:Deferiprone; D000077588:Deferasirox